Tumor Cell Invasion and the Tumor Microenvironment: Special Focus on Brain Tumors
- 19 October 2021
- book chapter
- Published by Springer Nature
- Vol. 1329, 109-121
Abstract
Tumor cell invasion is a major issue in oncology since it leads to tumor dissemination and recurrence. In glioblastomas, invasion is an important characteristic, making the disease difficult to treat since tumor recurrence occurs from invasive areas at the borders of the resection cavity. We are discussing herein some of the principal mechanisms at a cellular and molecular level that are involved in glioblastoma invasion. These mechanisms are comprising tumor cell intrinsic factors as well as extrinsic factors and cues produced by the tumor microenvironment. Therapeutically interfering with tumor cell invasion may be useful to improve the clinical outcomes of glioblastoma patients.Keywords
This publication has 68 references indexed in Scilit:
- Ion channels and tranporters in cancer. 2. Ion channels and the control of cancer cell migrationAmerican Journal of Physiology-Cell Physiology, 2011
- Bradykinin Promotes the Chemotactic Invasion of Primary Brain TumorsJournal of Neuroscience, 2011
- Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastomaProceedings of the National Academy of Sciences, 2011
- Extracellular Matrix: Functions in the Nervous SystemCold Spring Harbor Perspectives in Biology, 2010
- Role of Astrocytes in Brain Function and DiseaseToxicologic Pathology, 2010
- Thrombospondin 1—a key astrocyte‐derived neurogenic factorThe FASEB Journal, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1Cancer Research, 2009
- Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growthCancer Gene Therapy, 2008
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005